194 related articles for article (PubMed ID: 15316562)
1. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides.
Lau JP; Weatherdon KL; Skalski V; Hedley DW
Br J Cancer; 2004 Sep; 91(6):1166-73. PubMed ID: 15316562
[TBL] [Abstract][Full Text] [Related]
2. Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).
Lam W; Park SY; Leung CH; Cheng YC
Mol Pharmacol; 2006 May; 69(5):1607-14. PubMed ID: 16481390
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro.
Xiong GS; Sun HL; Wu SM; Mo JZ
J Dig Dis; 2010 Aug; 11(4):224-30. PubMed ID: 20649735
[TBL] [Abstract][Full Text] [Related]
4. Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1).
Zhang Y; Wang J
Chin J Cancer; 2010 Mar; 29(3):333-9. PubMed ID: 20193121
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor.
Yang S; Irani K; Heffron SE; Jurnak F; Meyskens FL
Mol Cancer Ther; 2005 Dec; 4(12):1923-35. PubMed ID: 16373707
[TBL] [Abstract][Full Text] [Related]
6. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
7. Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
Xu Z; Friess H; Solioz M; Aebi S; Korc M; Kleeff J; Büchler MW
Int J Cancer; 2001 Oct; 94(2):268-74. PubMed ID: 11668508
[TBL] [Abstract][Full Text] [Related]
8. Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death.
Cho KJ; Kim HJ; Park SC; Kim HW; Kim GW
Mol Cell Neurosci; 2010 Nov; 45(3):267-76. PubMed ID: 20637286
[TBL] [Abstract][Full Text] [Related]
9. Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.
Yang S; Meyskens FL
Antioxid Redox Signal; 2009 Mar; 11(3):639-50. PubMed ID: 18715151
[TBL] [Abstract][Full Text] [Related]
10. The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.
Lam W; Leung CH; Bussom S; Cheng YC
Mol Pharmacol; 2007 Sep; 72(3):536-44. PubMed ID: 17565005
[TBL] [Abstract][Full Text] [Related]
11. APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferation.
Merluzzi S; Gri G; Gattei V; Pagano M; Pucillo C
Mol Immunol; 2008 Aug; 45(14):3731-9. PubMed ID: 18617267
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy.
Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552
[TBL] [Abstract][Full Text] [Related]
13. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1.
Puppin C; Arturi F; Ferretti E; Russo D; Sacco R; Tell G; Damante G; Filetti S
Endocrinology; 2004 Mar; 145(3):1290-3. PubMed ID: 14630715
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
16. Purification and specific assays for measuring APE-1 endonuclease activity.
Esqueda A; Mohammed MZ; Madhusudan S; Neamati N
Methods Mol Biol; 2012; 928():161-74. PubMed ID: 22956141
[TBL] [Abstract][Full Text] [Related]
17. DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.
Shaikh AY; Martin LJ
Neuromolecular Med; 2002; 2(1):47-60. PubMed ID: 12230304
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
19. Apurinic/apyrimidinic endonuclease (APE/REF-1) haploinsufficient mice display tissue-specific differences in DNA polymerase beta-dependent base excision repair.
Raffoul JJ; Cabelof DC; Nakamura J; Meira LB; Friedberg EC; Heydari AR
J Biol Chem; 2004 Apr; 279(18):18425-33. PubMed ID: 14973123
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1.
Fritz G; Kaina B
Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
